Zepp Health Corporation has reported its financial results, highlighting a significant year-over-year revenue growth. The company projects its revenue for the third quarter to be between $72 million and $76 million, representing a 70% to 79% increase compared to the same period last year. This growth is attributed to strong execution and the positive market reception of recent product launches. Additionally, the company uses adjusted net income, a non-GAAP measure, to evaluate its performance, which excludes several factors such as share-based compensation expenses and amortization of intangible assets. This financial measure provides a clearer view of the company's operational performance without certain non-recurring expenses and gains.